Recent federal legislation and newly proposed DOL rules are reshaping the
pharmacy benefit management (PBM) landscape. These aren't just policy
shifts, they directly affect contract terms, ERISA fiduciary exposure, rebate
treatment, and pricing transparency.
Join regulatory experts and Jon Koval, PharmD, VP of Value Based
Pharmacy Care at Transcarent, for a clinical and market perspective on what
these changes mean for your pharmacy benefit strategy.
In this webinar, you'll: